A nationwide study found that TB history did not elevate long-term cancer risk among individuals living with HIV.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased apoptosis (shown in red) in several lung cell populations including ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

UC San Diego study of global lung cancer shows mutations that lead to cancer are common in people who live in cities with bad air pollution. But cancer mutations are quite close to normal among ...

Post-TB lung disease affects an estimated 60% of everyone who has been cured of TB. That is according to Dr Brian Allwood, a consultant pulmonologist at Stellenbosch University and Tygerberg Hospital.

Experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease, study suggests. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com ...